Paragon Care Ltd agreed to acquire a blood banking business unit from CSL Ltd for a total consideration of A$8.5 million.
Paragon will be acquiring the immunohematology unit from Seqirus IH, a CSL company. The acquisition will be funded through an existing debt facility and cash reserves.
The acquisition is expected to be settled between February and March 2018, Paragon said in a news release.
As of Nov. 30, US$1 was equivalent to A$1.32.
